This September, Novaptech will share its latest advances in aptamer-based biosensing at two major international events. Our teams will present how NOVAptamers and our proprietary NOVAswitch technology are opening new avenues for diagnostics, from animal health to neurodegenerative diseases.
📍 2nd International Conference on Infectious Diseases – Vienna, Austria (September 25–26, 2025)
Dr Jean-Jacques Toulmé, Chief Scientific Officer at Novaptech, will highlight the use of novel NOVAptamers for the detection of animal viruses, with a special focus on innovative approaches for air sample analysis. This technology holds significant promise for biosecurity applications and early outbreak detection.
📍 Satellite Workshop “Low-Dimensional Materials for Neuroscience and Biomedicine” – NanoBalkan 2025, Tirana (October 1, 2025)
Dr Sandeep Kumar, Research Engineer at Novaptech, will present the development of aptamers targeting early biomarkers of Alzheimer’s disease. These cutting-edge molecules could pave the way for earlier, less invasive diagnostic tools in neurodegenerative research.
These two events represent a unique opportunity to discover how NOVAptamers can be applied to real-world challenges in infectious diseases, neuroscience, and biosensing.
👉 If you would like to connect with Dr Jean-Jacques Toulmé or Dr Sandeep Kumar during these events, please reach out via contact@novaptech.com or on LinkedIn.
👉 Can’t attend? Learn more about NOVAptamer applications here: Contact us.
✨ These research programs are carried out with the financial support of the European Union.
EN 
FR